<?xml version="1.0" encoding="UTF-8"?>
<protein>
  <version>3.5</version>
  <creation_date>2013-01-15 18:51:44 -0700</creation_date>
  <update_date>2013-05-27 11:36:03 -0600</update_date>
  <accession>HMDBP00789</accession>
  <secondary_accessions>
    <accession>6069</accession>
    <accession>HMDBP03570</accession>
  </secondary_accessions>
  <protein_type>Unknown</protein_type>
  <synonyms>
    <synonym>AGT</synonym>
    <synonym>Alanine--glyoxylate aminotransferase</synonym>
    <synonym>SPT</synonym>
  </synonyms>
  <gene_name>AGXT</gene_name>
  <general_function>Involved in metabolic process</general_function>
  <specific_function></specific_function>
  <pathways>
    <pathway>
      <name>Alanine, aspartate and glutamate metabolism</name>
      <smpdb_id/>
      <kegg_map_id>map00250</kegg_map_id>
    </pathway>
    <pathway>
      <name>Glycine, serine and threonine metabolism</name>
      <smpdb_id/>
      <kegg_map_id>map00260</kegg_map_id>
    </pathway>
    <pathway>
      <name>Glyoxylate and dicarboxylate metabolism</name>
      <smpdb_id/>
      <kegg_map_id>map00630</kegg_map_id>
    </pathway>
    <pathway>
      <name>Peroxisome</name>
      <smpdb_id/>
      <kegg_map_id>map04146</kegg_map_id>
    </pathway>
  </pathways>
  <metabolite_associations>
    <metabolite>
      <accession>HMDB00243</accession>
      <name>Pyruvic acid</name>
    </metabolite>
    <metabolite>
      <accession>HMDB00161</accession>
      <name>L-Alanine</name>
    </metabolite>
    <metabolite>
      <accession>HMDB01352</accession>
      <name>Hydroxypyruvic acid</name>
    </metabolite>
    <metabolite>
      <accession>HMDB00187</accession>
      <name>L-Serine</name>
    </metabolite>
    <metabolite>
      <accession>HMDB00119</accession>
      <name>Glyoxylic acid</name>
    </metabolite>
    <metabolite>
      <accession>HMDB00123</accession>
      <name>Glycine</name>
    </metabolite>
    <metabolite>
      <accession>HMDB00464</accession>
      <name>Calcium</name>
    </metabolite>
    <metabolite>
      <accession>HMDB01491</accession>
      <name>Pyridoxal 5'-phosphate</name>
    </metabolite>
    <metabolite>
      <accession>HMDB00208</accession>
      <name>Oxoglutaric acid</name>
    </metabolite>
    <metabolite>
      <accession>HMDB00148</accession>
      <name>L-Glutamic acid</name>
    </metabolite>
  </metabolite_associations>
  <go_classifications>
    <go_class>
      <category>process</category>
      <description>metabolic process</description>
      <go_id/>
    </go_class>
    <go_class>
      <category>Cellular component</category>
      <description>mitochondrial matrix</description>
      <go_id>GO:0005759</go_id>
    </go_class>
    <go_class>
      <category>Cellular component</category>
      <description>peroxisomal matrix</description>
      <go_id>GO:0005782</go_id>
    </go_class>
    <go_class>
      <category>Molecular function</category>
      <description>alanine-glyoxylate transaminase activity</description>
      <go_id>GO:0008453</go_id>
    </go_class>
    <go_class>
      <category>Molecular function</category>
      <description>amino acid binding</description>
      <go_id>GO:0016597</go_id>
    </go_class>
    <go_class>
      <category>Molecular function</category>
      <description>protein homodimerization activity</description>
      <go_id>GO:0042803</go_id>
    </go_class>
    <go_class>
      <category>Molecular function</category>
      <description>pyridoxal phosphate binding</description>
      <go_id>GO:0030170</go_id>
    </go_class>
    <go_class>
      <category>Molecular function</category>
      <description>serine-pyruvate transaminase activity</description>
      <go_id>GO:0004760</go_id>
    </go_class>
    <go_class>
      <category>Biological process</category>
      <description>cellular nitrogen compound metabolic process</description>
      <go_id>GO:0034641</go_id>
    </go_class>
    <go_class>
      <category>Biological process</category>
      <description>glycine biosynthetic process, by transamination of glyoxylate</description>
      <go_id>GO:0019265</go_id>
    </go_class>
    <go_class>
      <category>Biological process</category>
      <description>glyoxylate catabolic process</description>
      <go_id>GO:0009436</go_id>
    </go_class>
    <go_class>
      <category>Biological process</category>
      <description>L-alanine catabolic process</description>
      <go_id>GO:0042853</go_id>
    </go_class>
    <go_class>
      <category>Biological process</category>
      <description>L-cysteine catabolic process</description>
      <go_id>GO:0019448</go_id>
    </go_class>
    <go_class>
      <category>Biological process</category>
      <description>oxalic acid secretion</description>
      <go_id>GO:0046724</go_id>
    </go_class>
    <go_class>
      <category>Biological process</category>
      <description>protein targeting to peroxisome</description>
      <go_id>GO:0006625</go_id>
    </go_class>
    <go_class>
      <category>Biological process</category>
      <description>pyruvate biosynthetic process</description>
      <go_id>GO:0042866</go_id>
    </go_class>
    <go_class>
      <category>Biological process</category>
      <description>response to cAMP</description>
      <go_id>GO:0051591</go_id>
    </go_class>
    <go_class>
      <category>Biological process</category>
      <description>response to glucocorticoid stimulus</description>
      <go_id>GO:0051384</go_id>
    </go_class>
  </go_classifications>
  <subcellular_locations>
    <subcellular_location>Peroxisome</subcellular_location>
    <subcellular_location>Mitochondrion matrix</subcellular_location>
  </subcellular_locations>
  <gene_properties>
    <chromosome_location>2</chromosome_location>
    <locus>2q37.3</locus>
    <gene_sequence>&gt;1179 bp
ATGGCCTCTCACAAGCTGCTGGTGACCCCCCCCAAGGCCCTGCTCAAGCCCCTCTCCATC
CCCAACCAGCTCCTGCTGGGGCCTGGTCCTTCCAACCTGCCTCCTCGCATCATGGCAGCC
GGGGGGCTGCAGATGATCGGGTCCATGAGCAAGGATATGTACCAGATCATGGACGAGATC
AAGGAAGGCATCCAGTACGTGTTCCAGACCAGGAACCCACTCACACTGGTCATCTCTGGC
TCGGGACACTGTGCCCTGGAGGCCGCCCTGGTCAATGTGCTGGAGCCTGGGGACTCCTTC
CTGGTTGGGGCCAATGGCATTTGGGGGCAGCGAGCCGTGGACATCGGGGAGCGCATAGGA
GCCCGAGTGCACCCGATGACCAAGGACCCTGGAGGCCACTACACACTGCAGGAGGTGGAG
GAGGGCCTGGCCCAGCACAAGCCAGTGCTGCTGTTCTTAACCCACGGGGAGTCGTCCACC
GGCGTGCTGCAGCCCCTTGATGGCTTCGGGGAACTCTGCCACAGGTACAAGTGCCTGCTC
CTGGTGGATTCGGTGGCATCCCTGGGCGGGACCCCCCTTTACATGGACCGGCAAGGCATC
GACATCCTGTACTCGGGCTCCCAGAAGGCCCTGAACGCCCCTCCAGGGACCTCGCTCATC
TCCTTCAGTGACAAGGCCAAAAAGAAGATGTACTCCCGCAAGACGAAGCCCTTCTCCTTC
TACCTGGACATCAAGTGGCTGGCCAACTTCTGGGGCTGTGACGACCAGCCCAGGATGTAC
CATCACACAATCCCCGTCATCAGCCTGTACAGCCTGAGAGAGAGCCTGGCCCTCATTGCG
GAACAGGGCCTGGAGAACAGCTGGCGCCAGCACCGCGAGGCCGCGGCGTATCTGCATGGG
CGCCTGCAGGCACTGGGGCTGCAGCTCTTCGTGAAGGACCCGGCGCTCCGGCTTCCCACA
GTCACCACTGTGGCTGTACCCGCTGGCTATGACTGGAGAGACATCGTCAGCTACGTCATA
GACCACTTCGACATTGAGATCATGGGTGGCCTTGGGCCCTCCACGGGGAAGGTGCTGCGG
ATCGGCCTGCTGGGCTGCAATGCCACCCGCGAGAATGTGGACCGCGTGACGGAGGCCCTG
AGGGCGGCCCTGCAGCACTGCCCCAAGAAGAAGCTGTGA</gene_sequence>
  </gene_properties>
  <protein_properties>
    <residue_number>392</residue_number>
    <molecular_weight>43009.535</molecular_weight>
    <theoretical_pi>8.393</theoretical_pi>
    <pfams>
      <pfam>
        <name>Aminotran_5</name>
        <pfam_id>PF00266</pfam_id>
      </pfam>
    </pfams>
    <transmembrane_regions>
    </transmembrane_regions>
    <signal_regions>
    </signal_regions>
    <protein_sequence>&gt;Serine--pyruvate aminotransferase
MASHKLLVTPPKALLKPLSIPNQLLLGPGPSNLPPRIMAAGGLQMIGSMSKDMYQIMDEI
KEGIQYVFQTRNPLTLVISGSGHCALEAALVNVLEPGDSFLVGANGIWGQRAVDIGERIG
ARVHPMTKDPGGHYTLQEVEEGLAQHKPVLLFLTHGESSTGVLQPLDGFGELCHRYKCLL
LVDSVASLGGTPLYMDRQGIDILYSGSQKALNAPPGTSLISFSDKAKKKMYSRKTKPFSF
YLDIKWLANFWGCDDQPRMYHHTIPVISLYSLRESLALIAEQGLENSWRQHREAAAYLHG
RLQALGLQLFVKDPALRLPTVTTVAVPAGYDWRDIVSYVIDHFDIEIMGGLGPSTGKVLR
IGLLGCNATRENVDRVTEALRAALQHCPKKKL</protein_sequence>
  </protein_properties>
  <genbank_protein_id>36582</genbank_protein_id>
  <uniprot_id>P21549</uniprot_id>
  <uniprot_name>SPYA_HUMAN</uniprot_name>
  <pdb_ids>
    <pdb_id>1H0C</pdb_id>
    <pdb_id>1J04</pdb_id>
    <pdb_id>3R9A</pdb_id>
  </pdb_ids>
  <genbank_gene_id>X56092</genbank_gene_id>
  <genecard_id>AGXT</genecard_id>
  <geneatlas_id>AGXT</geneatlas_id>
  <hgnc_id>HGNC:341</hgnc_id>
  <general_references>
    <reference>
      <reference_text>Nishiyama K, Berstein G, Oda T, Ichiyama A: Cloning and nucleotide sequence of cDNA encoding human liver serine-pyruvate aminotransferase. Eur J Biochem. 1990 Nov 26;194(1):9-18.</reference_text>
      <pubmed_id>2253628</pubmed_id>
    </reference>
    <reference>
      <reference_text>Purdue PE, Takada Y, Danpure CJ: Identification of mutations associated with peroxisome-to-mitochondrion mistargeting of alanine/glyoxylate aminotransferase in primary hyperoxaluria type 1. J Cell Biol. 1990 Dec;111(6 Pt 1):2341-51.</reference_text>
      <pubmed_id>1703535</pubmed_id>
    </reference>
    <reference>
      <reference_text>Takada Y, Kaneko N, Esumi H, Purdue PE, Danpure CJ: Human peroxisomal L-alanine: glyoxylate aminotransferase. Evolutionary loss of a mitochondrial targeting signal by point mutation of the initiation codon. Biochem J. 1990 Jun 1;268(2):517-20.</reference_text>
      <pubmed_id>2363689</pubmed_id>
    </reference>
    <reference>
      <reference_text>Purdue PE, Lumb MJ, Fox M, Griffo G, Hamon-Benais C, Povey S, Danpure CJ: Characterization and chromosomal mapping of a genomic clone encoding human alanine:glyoxylate aminotransferase. Genomics. 1991 May;10(1):34-42.</reference_text>
      <pubmed_id>2045108</pubmed_id>
    </reference>
    <reference>
      <reference_text>Ota T, Suzuki Y, Nishikawa T, Otsuki T, Sugiyama T, Irie R, Wakamatsu A, Hayashi K, Sato H, Nagai K, Kimura K, Makita H, Sekine M, Obayashi M, Nishi T, Shibahara T, Tanaka T, Ishii S, Yamamoto J, Saito K, Kawai Y, Isono Y, Nakamura Y, Nagahari K, Murakami K, Yasuda T, Iwayanagi T, Wagatsuma M, Shiratori A, Sudo H, Hosoiri T, Kaku Y, Kodaira H, Kondo H, Sugawara M, Takahashi M, Kanda K, Yokoi T, Furuya T, Kikkawa E, Omura Y, Abe K, Kamihara K, Katsuta N, Sato K, Tanikawa M, Yamazaki M, Ninomiya K, Ishibashi T, Yamashita H, Murakawa K, Fujimori K, Tanai H, Kimata M, Watanabe M, Hiraoka S, Chiba Y, Ishida S, Ono Y, Takiguchi S, Watanabe S, Yosida M, Hotuta T, Kusano J, Kanehori K, Takahashi-Fujii A, Hara H, Tanase TO, Nomura Y, Togiya S, Komai F, Hara R, Takeuchi K, Arita M, Imose N, Musashino K, Yuuki H, Oshima A, Sasaki N, Aotsuka S, Yoshikawa Y, Matsunawa H, Ichihara T, Shiohata N, Sano S, Moriya S, Momiyama H, Satoh N, Takami S, Terashima Y, Suzuki O, Nakagawa S, Senoh A, Mizoguchi H, Goto Y, Shimizu F, Wakebe H, Hishigaki H, Watanabe T, Sugiyama A, Takemoto M, Kawakami B, Yamazaki M, Watanabe K, Kumagai A, Itakura S, Fukuzumi Y, Fujimori Y, Komiyama M, Tashiro H, Tanigami A, Fujiwara T, Ono T, Yamada K, Fujii Y, Ozaki K, Hirao M, Ohmori Y, Kawabata A, Hikiji T, Kobatake N, Inagaki H, Ikema Y, Okamoto S, Okitani R, Kawakami T, Noguchi S, Itoh T, Shigeta K, Senba T, Matsumura K, Nakajima Y, Mizuno T, Morinaga M, Sasaki M, Togashi T, Oyama M, Hata H, Watanabe M, Komatsu T, Mizushima-Sugano J, Satoh T, Shirai Y, Takahashi Y, Nakagawa K, Okumura K, Nagase T, Nomura N, Kikuchi H, Masuho Y, Yamashita R, Nakai K, Yada T, Nakamura Y, Ohara O, Isogai T, Sugano S: Complete sequencing and characterization of 21,243 full-length human cDNAs. Nat Genet. 2004 Jan;36(1):40-5. Epub 2003 Dec 21.</reference_text>
      <pubmed_id>14702039</pubmed_id>
    </reference>
    <reference>
      <reference_text>Hillier LW, Graves TA, Fulton RS, Fulton LA, Pepin KH, Minx P, Wagner-McPherson C, Layman D, Wylie K, Sekhon M, Becker MC, Fewell GA, Delehaunty KD, Miner TL, Nash WE, Kremitzki C, Oddy L, Du H, Sun H, Bradshaw-Cordum H, Ali J, Carter J, Cordes M, Harris A, Isak A, van Brunt A, Nguyen C, Du F, Courtney L, Kalicki J, Ozersky P, Abbott S, Armstrong J, Belter EA, Caruso L, Cedroni M, Cotton M, Davidson T, Desai A, Elliott G, Erb T, Fronick C, Gaige T, Haakenson W, Haglund K, Holmes A, Harkins R, Kim K, Kruchowski SS, Strong CM, Grewal N, Goyea E, Hou S, Levy A, Martinka S, Mead K, McLellan MD, Meyer R, Randall-Maher J, Tomlinson C, Dauphin-Kohlberg S, Kozlowicz-Reilly A, Shah N, Swearengen-Shahid S, Snider J, Strong JT, Thompson J, Yoakum M, Leonard S, Pearman C, Trani L, Radionenko M, Waligorski JE, Wang C, Rock SM, Tin-Wollam AM, Maupin R, Latreille P, Wendl MC, Yang SP, Pohl C, Wallis JW, Spieth J, Bieri TA, Berkowicz N, Nelson JO, Osborne J, Ding L, Meyer R, Sabo A, Shotland Y, Sinha P, Wohldmann PE, Cook LL, Hickenbotham MT, Eldred J, Williams D, Jones TA, She X, Ciccarelli FD, Izaurralde E, Taylor J, Schmutz J, Myers RM, Cox DR, Huang X, McPherson JD, Mardis ER, Clifton SW, Warren WC, Chinwalla AT, Eddy SR, Marra MA, Ovcharenko I, Furey TS, Miller W, Eichler EE, Bork P, Suyama M, Torrents D, Waterston RH, Wilson RK: Generation and annotation of the DNA sequences of human chromosomes 2 and 4. Nature. 2005 Apr 7;434(7034):724-31.</reference_text>
      <pubmed_id>15815621</pubmed_id>
    </reference>
    <reference>
      <reference_text>Gerhard DS, Wagner L, Feingold EA, Shenmen CM, Grouse LH, Schuler G, Klein SL, Old S, Rasooly R, Good P, Guyer M, Peck AM, Derge JG, Lipman D, Collins FS, Jang W, Sherry S, Feolo M, Misquitta L, Lee E, Rotmistrovsky K, Greenhut SF, Schaefer CF, Buetow K, Bonner TI, Haussler D, Kent J, Kiekhaus M, Furey T, Brent M, Prange C, Schreiber K, Shapiro N, Bhat NK, Hopkins RF, Hsie F, Driscoll T, Soares MB, Casavant TL, Scheetz TE, Brown-stein MJ, Usdin TB, Toshiyuki S, Carninci P, Piao Y, Dudekula DB, Ko MS, Kawakami K, Suzuki Y, Sugano S, Gruber CE, Smith MR, Simmons B, Moore T, Waterman R, Johnson SL, Ruan Y, Wei CL, Mathavan S, Gunaratne PH, Wu J, Garcia AM, Hulyk SW, Fuh E, Yuan Y, Sneed A, Kowis C, Hodgson A, Muzny DM, McPherson J, Gibbs RA, Fahey J, Helton E, Ketteman M, Madan A, Rodrigues S, Sanchez A, Whiting M, Madari A, Young AC, Wetherby KD, Granite SJ, Kwong PN, Brinkley CP, Pearson RL, Bouffard GG, Blakesly RW, Green ED, Dickson MC, Rodriguez AC, Grimwood J, Schmutz J, Myers RM, Butterfield YS, Griffith M, Griffith OL, Krzywinski MI, Liao N, Morin R, Palmquist D, Petrescu AS, Skalska U, Smailus DE, Stott JM, Schnerch A, Schein JE, Jones SJ, Holt RA, Baross A, Marra MA, Clifton S, Makowski KA, Bosak S, Malek J: The status, quality, and expansion of the NIH full-length cDNA project: the Mammalian Gene Collection (MGC). Genome Res. 2004 Oct;14(10B):2121-7.</reference_text>
      <pubmed_id>15489334</pubmed_id>
    </reference>
    <reference>
      <reference_text>Zhang X, Roe SM, Hou Y, Bartlam M, Rao Z, Pearl LH, Danpure CJ: Crystal structure of alanine:glyoxylate aminotransferase and the relationship between genotype and enzymatic phenotype in primary hyperoxaluria type 1. J Mol Biol. 2003 Aug 15;331(3):643-52.</reference_text>
      <pubmed_id>12899834</pubmed_id>
    </reference>
    <reference>
      <reference_text>Nishiyama K, Funai T, Katafuchi R, Hattori F, Onoyama K, Ichiyama A: Primary hyperoxaluria type I due to a point mutation of T to C in the coding region of the serine:pyruvate aminotransferase gene. Biochem Biophys Res Commun. 1991 May 15;176(3):1093-9.</reference_text>
      <pubmed_id>2039493</pubmed_id>
    </reference>
    <reference>
      <reference_text>Purdue PE, Lumb MJ, Allsop J, Minatogawa Y, Danpure CJ: A glycine-to-glutamate substitution abolishes alanine:glyoxylate aminotransferase catalytic activity in a subset of patients with primary hyperoxaluria type 1. Genomics. 1992 May;13(1):215-8.</reference_text>
      <pubmed_id>1349575</pubmed_id>
    </reference>
    <reference>
      <reference_text>Minatogawa Y, Tone S, Allsop J, Purdue PE, Takada Y, Danpur CJ, Kido R: A serine-to-phenylalanine substitution leads to loss of alanine:glyoxylate aminotransferase catalytic activity and immunoreactivity in a patient with primary hyperoxaluria type 1. Hum Mol Genet. 1992 Nov;1(8):643-4.</reference_text>
      <pubmed_id>1301173</pubmed_id>
    </reference>
    <reference>
      <reference_text>Danpure CJ, Purdue PE, Fryer P, Griffiths S, Allsop J, Lumb MJ, Guttridge KM, Jennings PR, Scheinman JI, Mauer SM, et al.: Enzymological and mutational analysis of a complex primary hyperoxaluria type 1 phenotype involving alanine:glyoxylate aminotransferase peroxisome-to-mitochondrion mistargeting and intraperoxisomal aggregation. Am J Hum Genet. 1993 Aug;53(2):417-32.</reference_text>
      <pubmed_id>8101040</pubmed_id>
    </reference>
    <reference>
      <reference_text>Danpure CJ: Primary hyperoxaluria type 1 and peroxisome-to-mitochondrion mistargeting of alanine:glyoxylate aminotransferase. Biochimie. 1993;75(3-4):309-15.</reference_text>
      <pubmed_id>8507692</pubmed_id>
    </reference>
    <reference>
      <reference_text>von Schnakenburg C, Rumsby G: Primary hyperoxaluria type 1: a cluster of new mutations in exon 7 of the AGXT gene. J Med Genet. 1997 Jun;34(6):489-92.</reference_text>
      <pubmed_id>9192270</pubmed_id>
    </reference>
    <reference>
      <reference_text>von Schnakenburg C, Rumsby G: Identification of new mutations in primary hyperoxaluria type 1 (PH1).  J Nephrol. 1998 Mar-Apr;11 Suppl 1:15-7.</reference_text>
      <pubmed_id>9604803</pubmed_id>
    </reference>
    <reference>
      <reference_text>Amoroso A, Pirulli D, Puzzer D, Ferri L, Crovella S, Ferrettini C, Marangella M, Mazzola G, Florian F: Gene symbol: AGXT. Disease: primary hyperoxaluria type I.  Hum Genet. 1999 May;104(5):441.</reference_text>
      <pubmed_id>10394939</pubmed_id>
    </reference>
    <reference>
      <reference_text>Pirulli D, Puzzer D, Ferri L, Crovella S, Amoroso A, Ferrettini C, Marangella M, Mazzola G, Florian F: Molecular analysis of hyperoxaluria type 1 in Italian patients reveals eight new mutations in the alanine: glyoxylate aminotransferase gene. Hum Genet. 1999 Jun;104(6):523-5.</reference_text>
      <pubmed_id>10453743</pubmed_id>
    </reference>
    <reference>
      <reference_text>Rinat C, Wanders RJ, Drukker A, Halle D, Frishberg Y: Primary hyperoxaluria type I: a model for multiple mutations in a monogenic disease within a distinct ethnic group. J Am Soc Nephrol. 1999 Nov;10(11):2352-8.</reference_text>
      <pubmed_id>10541294</pubmed_id>
    </reference>
    <reference>
      <reference_text>Basmaison O, Rolland MO, Cochat P, Bozon D: Identification of 5 novel mutations in the AGXT gene.  Hum Mutat. 2000 Jun;15(6):577.</reference_text>
      <pubmed_id>10862087</pubmed_id>
    </reference>
    <reference>
      <reference_text>Lumb MJ, Danpure CJ: Functional synergism between the most common polymorphism in human alanine:glyoxylate aminotransferase and four of the most common disease-causing mutations. J Biol Chem. 2000 Nov 17;275(46):36415-22.</reference_text>
      <pubmed_id>10960483</pubmed_id>
    </reference>
    <reference>
      <reference_text>Coulter-Mackie MB, Tung A, Henderson HE, Toone JR, Applegarth DA: The AGT gene in Africa: a distinctive minor allele haplotype, a polymorphism (V326I), and a novel PH1 mutation (A112D) in Black Africans. Mol Genet Metab. 2003 Jan;78(1):44-50.</reference_text>
      <pubmed_id>12559847</pubmed_id>
    </reference>
    <reference>
      <reference_text>Santana A, Salido E, Torres A, Shapiro LJ: Primary hyperoxaluria type 1 in the Canary Islands: a conformational disease due to I244T mutation in the P11L-containing alanine:glyoxylate aminotransferase. Proc Natl Acad Sci U S A. 2003 Jun 10;100(12):7277-82. Epub 2003 May 30.</reference_text>
      <pubmed_id>12777626</pubmed_id>
    </reference>
    <reference>
      <reference_text>van Woerden CS, Groothoff JW, Wijburg FA, Annink C, Wanders RJ, Waterham HR: Clinical implications of mutation analysis in primary hyperoxaluria type 1. Kidney Int. 2004 Aug;66(2):746-52.</reference_text>
      <pubmed_id>15253729</pubmed_id>
    </reference>
    <reference>
      <reference_text>Monico CG, Olson JB, Milliner DS: Implications of genotype and enzyme phenotype in pyridoxine response of patients with type I primary hyperoxaluria. Am J Nephrol. 2005 Mar-Apr;25(2):183-8. Epub 2005 Apr 21.</reference_text>
      <pubmed_id>15849466</pubmed_id>
    </reference>
    <reference>
      <reference_text>Frishberg Y, Rinat C, Shalata A, Khatib I, Feinstein S, Becker-Cohen R, Weismann I, Wanders RJ, Rumsby G, Roels F, Mandel H: Intra-familial clinical heterogeneity: absence of genotype-phenotype correlation in primary hyperoxaluria type 1 in Israel. Am J Nephrol. 2005 May-Jun;25(3):269-75. Epub 2005 Jun 15.</reference_text>
      <pubmed_id>15961946</pubmed_id>
    </reference>
    <reference>
      <reference_text>Coulter-Mackie MB, Lian Q, Applegarth D, Toone J: The major allele of the alanine:glyoxylate aminotransferase gene: nine novel mutations and polymorphisms associated with primary hyperoxaluria type 1. Mol Genet Metab. 2005 Sep-Oct;86(1-2):172-8. Epub 2005 Jun 15.</reference_text>
      <pubmed_id>15963748</pubmed_id>
    </reference>
  </general_references>
  <metabolite_references>
    <metabolite_reference>
      <metabolite>
        <name>L-Alanine</name>
        <accession>HMDB00161</accession>
      </metabolite>
      <reference>
        <reference_text>Overington JP, Al-Lazikani B, Hopkins AL: How many drug targets are there?  Nat Rev Drug Discov. 2006 Dec;5(12):993-6.</reference_text>
        <pubmed_id>17139284</pubmed_id>
      </reference>
    </metabolite_reference>
    <metabolite_reference>
      <metabolite>
        <name>L-Alanine</name>
        <accession>HMDB00161</accession>
      </metabolite>
      <reference>
        <reference_text>Imming P, Sinning C, Meyer A: Drugs, their targets and the nature and number of drug targets.  Nat Rev Drug Discov. 2006 Oct;5(10):821-34.</reference_text>
        <pubmed_id>17016423</pubmed_id>
      </reference>
    </metabolite_reference>
    <metabolite_reference>
      <metabolite>
        <name>L-Alanine</name>
        <accession>HMDB00161</accession>
      </metabolite>
      <reference>
        <reference_text>Salido EC, Li XM, Lu Y, Wang X, Santana A, Roy-Chowdhury N, Torres A, Shapiro LJ, Roy-Chowdhury J: Alanine-glyoxylate aminotransferase-deficient mice, a model for primary hyperoxaluria that responds to adenoviral gene transfer. Proc Natl Acad Sci U S A. 2006 Nov 28;103(48):18249-54. Epub 2006 Nov 16.</reference_text>
        <pubmed_id>17110443</pubmed_id>
      </reference>
    </metabolite_reference>
    <metabolite_reference>
      <metabolite>
        <name>L-Alanine</name>
        <accession>HMDB00161</accession>
      </metabolite>
      <reference>
        <reference_text>Amoroso A, Pirulli D, Florian F, Puzzer D, Boniotto M, Crovella S, Zezlina S, Spano A, Mazzola G, Savoldi S, Ferrettini C, Berutti S, Petrarulo M, Marangella M: AGXT gene mutations and their influence on clinical heterogeneity of type 1 primary hyperoxaluria. J Am Soc Nephrol. 2001 Oct;12(10):2072-9.</reference_text>
        <pubmed_id>11562405</pubmed_id>
      </reference>
    </metabolite_reference>
    <metabolite_reference>
      <metabolite>
        <name>L-Alanine</name>
        <accession>HMDB00161</accession>
      </metabolite>
      <reference>
        <reference_text>Pirulli D, Puzzer D, Ferri L, Crovella S, Amoroso A, Ferrettini C, Marangella M, Mazzola G, Florian F: Molecular analysis of hyperoxaluria type 1 in Italian patients reveals eight new mutations in the alanine: glyoxylate aminotransferase gene. Hum Genet. 1999 Jun;104(6):523-5.</reference_text>
        <pubmed_id>10453743</pubmed_id>
      </reference>
    </metabolite_reference>
    <metabolite_reference>
      <metabolite>
        <name>L-Serine</name>
        <accession>HMDB00187</accession>
      </metabolite>
      <reference>
        <reference_text>Ikushiro H, Islam MM, Tojo H, Hayashi H: Molecular characterization of membrane-associated soluble serine palmitoyltransferases from Sphingobacterium multivorum and Bdellovibrio stolpii. J Bacteriol. 2007 Aug;189(15):5749-61. Epub 2007 Jun 8.</reference_text>
        <pubmed_id>17557831</pubmed_id>
      </reference>
    </metabolite_reference>
    <metabolite_reference>
      <metabolite>
        <name>L-Serine</name>
        <accession>HMDB00187</accession>
      </metabolite>
      <reference>
        <reference_text>Cowart LA, Hannun YA: Selective substrate supply in the regulation of yeast de novo sphingolipid synthesis. J Biol Chem. 2007 Apr 20;282(16):12330-40. Epub 2007 Feb 23.</reference_text>
        <pubmed_id>17322298</pubmed_id>
      </reference>
    </metabolite_reference>
    <metabolite_reference>
      <metabolite>
        <name>L-Serine</name>
        <accession>HMDB00187</accession>
      </metabolite>
      <reference>
        <reference_text>Son JH, Yoo HH, Kim DH: Activation of de novo synthetic pathway of ceramides is responsible for the initiation of hydrogen peroxide-induced apoptosis in HL-60 cells. J Toxicol Environ Health A. 2007 Aug;70(15-16):1310-8.</reference_text>
        <pubmed_id>17654249</pubmed_id>
      </reference>
    </metabolite_reference>
    <metabolite_reference>
      <metabolite>
        <name>L-Serine</name>
        <accession>HMDB00187</accession>
      </metabolite>
      <reference>
        <reference_text>Yard BA, Carter LG, Johnson KA, Overton IM, Dorward M, Liu H, McMahon SA, Oke M, Puech D, Barton GJ, Naismith JH, Campopiano DJ: The structure of serine palmitoyltransferase; gateway to sphingolipid biosynthesis. J Mol Biol. 2007 Jul 27;370(5):870-86. Epub 2007 May 10.</reference_text>
        <pubmed_id>17559874</pubmed_id>
      </reference>
    </metabolite_reference>
    <metabolite_reference>
      <metabolite>
        <name>Glycine</name>
        <accession>HMDB00123</accession>
      </metabolite>
      <reference>
        <reference_text>Ricoult C, Echeverria LO, Cliquet JB, Limami AM: Characterization of alanine aminotransferase (AlaAT) multigene family and hypoxic response in young seedlings of the model legume Medicago truncatula. J Exp Bot. 2006;57(12):3079-89. Epub 2006 Aug 9.</reference_text>
        <pubmed_id>16899523</pubmed_id>
      </reference>
    </metabolite_reference>
    <metabolite_reference>
      <metabolite>
        <name>Glycine</name>
        <accession>HMDB00123</accession>
      </metabolite>
      <reference>
        <reference_text>Han Q, Robinson H, Gao YG, Vogelaar N, Wilson SR, Rizzi M, Li J: Crystal structures of Aedes aegypti alanine glyoxylate aminotransferase.  J Biol Chem. 2006 Dec 1;281(48):37175-82. Epub 2006 Sep 21.</reference_text>
        <pubmed_id>16990263</pubmed_id>
      </reference>
    </metabolite_reference>
    <metabolite_reference>
      <metabolite>
        <name>Glycine</name>
        <accession>HMDB00123</accession>
      </metabolite>
      <reference>
        <reference_text>Lu TC, Ko YZ, Huang HW, Hung YC, Lin YC, Peng WH: Analgesic and anti-inflammatory activities of aqueous extract from Glycine tomentella root in mice. J Ethnopharmacol. 2007 Aug 15;113(1):142-8. Epub 2007 May 31.</reference_text>
        <pubmed_id>17616291</pubmed_id>
      </reference>
    </metabolite_reference>
  </metabolite_references>
</protein>
